• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Champions Oncology, Inc. - Common Stock (NQ:CSBR)

6.145 -0.175 (-2.77%)
Streaming Delayed Price Updated: 1:18 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,433
Open 6.320
Bid (Size) 6.100 (1)
Ask (Size) 6.200 (2)
Prev. Close 6.320
Today's Range 5.850 - 6.320
52wk Range 3.600 - 11.99
Shares Outstanding 13,415,066
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Champions Oncology Reports Record Annual Revenue of $57 Million
July 23, 2025
Via ACCESS Newswire
Earnings Scheduled For July 23, 2025
July 23, 2025
 
Via Benzinga

Performance

YTD
-25.1%
-25.1%
1 Month
-14.8%
-14.8%
3 Month
-3.7%
-3.7%
6 Month
-42.6%
-42.6%
1 Year
+28.3%
+28.3%

More News

Read More
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025
July 21, 2025
Via ACCESS Newswire
Champions Oncology Announces Appointment of New CEO
July 18, 2025
Via ACCESS Newswire
Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models
July 08, 2025
Via ACCESS Newswire
Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House
April 28, 2025
Via ACCESS Newswire
Recap: Champions Oncology Q2 Earnings
December 11, 2024
Via Benzinga
A Peek at Champions Oncology's Future Earnings
December 10, 2024
Via Benzinga
A Preview Of Champions Oncology's Earnings
September 10, 2024
Via Benzinga
Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine
April 24, 2025
Via ACCESS Newswire
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million
March 11, 2025
Via ACCESS Newswire
Earnings Scheduled For March 11, 2025
March 11, 2025
Via Benzinga
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025
March 06, 2025
Via ACCESS Newswire
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
February 18, 2025
Via ACCESS Newswire
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket
January 28, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
January 17, 2025
Via Benzinga
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
January 08, 2025
Via ACCESSWIRE
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million
December 11, 2024
Via ACCESSWIRE
Earnings Scheduled For December 11, 2024
December 11, 2024
Via Benzinga
Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024
December 05, 2024
Via ACCESSWIRE
Champions Oncology Announces Agreement with Weill Cornell Medicine
October 16, 2024
Via ACCESSWIRE
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
September 12, 2024
Via Benzinga
Kroger, Adobe And 3 Stocks To Watch Heading Into Thursday
September 12, 2024
Via Benzinga
Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million
September 11, 2024
Via ACCESSWIRE
Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024
September 09, 2024
Via ACCESSWIRE

Frequently Asked Questions

Is Champions Oncology, Inc. - Common Stock publicly traded?
Yes, Champions Oncology, Inc. - Common Stock is publicly traded.
What exchange does Champions Oncology, Inc. - Common Stock trade on?
Champions Oncology, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Champions Oncology, Inc. - Common Stock?
The ticker symbol for Champions Oncology, Inc. - Common Stock is CSBR on the Nasdaq Stock Market
What is the current price of Champions Oncology, Inc. - Common Stock?
The current price of Champions Oncology, Inc. - Common Stock is 6.145
When was Champions Oncology, Inc. - Common Stock last traded?
The last trade of Champions Oncology, Inc. - Common Stock was at 08/01/25 01:18 PM ET
What is the market capitalization of Champions Oncology, Inc. - Common Stock?
The market capitalization of Champions Oncology, Inc. - Common Stock is 82.44M
How many shares of Champions Oncology, Inc. - Common Stock are outstanding?
Champions Oncology, Inc. - Common Stock has 82M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap